154 related articles for article (PubMed ID: 37243721)
21. Brain lesion-pattern analysis in patients with olfactory dysfunctions following head trauma.
Lötsch J; Ultsch A; Eckhardt M; Huart C; Rombaux P; Hummel T
Neuroimage Clin; 2016; 11():99-105. PubMed ID: 26937377
[TBL] [Abstract][Full Text] [Related]
22. Assessment of postviral qualitative olfactory dysfunction using the short SSParoT in patients with and without parosmia.
Sekine R; Menzel S; Hähner A; Mori E; Hummel T
Eur Arch Otorhinolaryngol; 2023 Jan; 280(1):469-472. PubMed ID: 36006515
[TBL] [Abstract][Full Text] [Related]
23. Phantosmia May Predict Long-Term Measurable Olfactory Dysfunction After COVID-19.
Leung JS; Cordano VP; Fuentes-López E; Lagos AE; García-Huidobro FG; Aliaga R; Díaz LA; García-Salum T; Salinas E; Toro A; Callejas CA; Riquelme A; Palmer JN; Medina RA; González G C
Laryngoscope; 2022 Dec; 132(12):2445-2452. PubMed ID: 36149773
[TBL] [Abstract][Full Text] [Related]
24. Parosmia is Associated with Relevant Olfactory Recovery After Olfactory Training.
Liu DT; Sabha M; Damm M; Philpott C; Oleszkiewicz A; Hähner A; Hummel T
Laryngoscope; 2021 Mar; 131(3):618-623. PubMed ID: 33210732
[TBL] [Abstract][Full Text] [Related]
25. Recovery From COVID-19-Related Olfactory Disorders and Quality of Life: Insights From an Observational Online Study.
Ferdenzi C; Bousquet C; Aguera PE; Dantec M; Daudé C; Fornoni L; Fournel A; Kassan A; Mantel M; Moranges M; Moussy E; Richard Ortegón S; Rouby C; Bensafi M
Chem Senses; 2021 Jan; 46():. PubMed ID: 34097726
[TBL] [Abstract][Full Text] [Related]
26. Parosmia Is Positively Associated With Problematic Drinking, as Is Phantosmia With Depressive Symptoms.
Agarwal K; Luk JW; Stangl BL; Schwandt ML; Momenan R; Goldman D; Diazgranados N; Kareken DA; Leggio L; Ramchandani VA; Joseph PV
J Addict Med; 2024 May; ():. PubMed ID: 38776446
[TBL] [Abstract][Full Text] [Related]
27. Proof-of-concept: SCENTinel 1.1 rapidly discriminates COVID-19 related olfactory disorders.
Hunter SR; Hannum ME; Pellegrino R; O'Leary MA; Rawson NE; Reed DR; Dalton PH; Parma V
medRxiv; 2022 Nov; ():. PubMed ID: 35350197
[TBL] [Abstract][Full Text] [Related]
28. The Role of Social Media in Improving Patient Recruitment for Research Studies on Persistent Post-Infectious Olfactory Dysfunction.
Pendolino AL; Navaratnam AV; Nijim J; Kelly CE; Randhawa PS; Andrews PJ
Medicina (Kaunas); 2022 Feb; 58(3):. PubMed ID: 35334524
[No Abstract] [Full Text] [Related]
29. Persistent olfactory dysfunction in mild COVID-19 patients: A descriptive study of the characteristics and association with other symptoms.
García-Meléndez DD; Morales-Casado MI; Quintana Castro P; Marsal Alonso C
Med Clin (Barc); 2023 Apr; 160(8):347-351. PubMed ID: 36670030
[TBL] [Abstract][Full Text] [Related]
30. Development and Validation of the Parosmia Olfactory Dysfunction Outcomes Rating (DisODOR).
Ioerger P; Kallogjeri D; Roland L; Schneider JS; Piccirillo JF; Farrell NF
Otolaryngol Head Neck Surg; 2023 Dec; 169(6):1654-1661. PubMed ID: 37622602
[TBL] [Abstract][Full Text] [Related]
31. Modified Olfactory Training Is an Effective Treatment Method for COVID-19 Induced Parosmia.
Altundag A; Yilmaz E; Kesimli MC
Laryngoscope; 2022 Jul; 132(7):1433-1438. PubMed ID: 35257391
[TBL] [Abstract][Full Text] [Related]
32. Stellate ganglion block for treating post-COVID-19 parosmia.
Naimi BR; Garvey E; Chandna M; Duffy A; Hunter SR; Mandloi S; Kahn C; Farquhar D; D'Souza G; Rabinowitz M; Rosen M; Toskala E; Roedl JB; Zoga A; Nyquist G; Rosen D
Int Forum Allergy Rhinol; 2024 Jun; 14(6):1088-1096. PubMed ID: 38226898
[TBL] [Abstract][Full Text] [Related]
33. Remote psychophysical testing of smell in patients with persistent olfactory dysfunction after COVID-19.
Martončíková M; Doležal P; Fabianová K; Karhánek M; Gálik J; Raček A; Popovičová A; Račeková E
Sci Rep; 2023 Aug; 13(1):14090. PubMed ID: 37640847
[TBL] [Abstract][Full Text] [Related]
34. Prevalence and 24-month recovery of olfactory dysfunction in COVID-19 patients: A multicentre prospective study.
Lechien JR; Vaira LA; Saussez S
J Intern Med; 2023 Jan; 293(1):82-90. PubMed ID: 36000469
[TBL] [Abstract][Full Text] [Related]
35. Qualitative Olfactory Disorders: Patient Experiences and Self-Management.
Philpott C; Dixon J; Boak D
Allergy Rhinol (Providence); 2021; 12():21526567211004251. PubMed ID: 34589267
[TBL] [Abstract][Full Text] [Related]
36. Phantosmia, Parosmia, and Dysgeusia Are Prolonged and Late-Onset Symptoms of COVID-19.
Schambeck SE; Crowell CS; Wagner KI; D'Ippolito E; Burrell T; Mijočević H; Protzer U; Busch DH; Gerhard M; Poppert H; Beyer H
J Clin Med; 2021 Nov; 10(22):. PubMed ID: 34830550
[TBL] [Abstract][Full Text] [Related]
37. Euosmia: a rare form of parosmia.
Landis BN; Frasnelli J; Hummel T
Acta Otolaryngol; 2006 Jan; 126(1):101-3. PubMed ID: 16308262
[TBL] [Abstract][Full Text] [Related]
38. Recovery rates and parosmia in olfactory loss during the COVID-19 era.
Schwab J; Fjaeldstad AW
Dan Med J; 2022 Aug; 69(9):. PubMed ID: 36065887
[TBL] [Abstract][Full Text] [Related]
39. Prevalence and assessment of qualitative olfactory dysfunction in different age groups.
Nordin S; Murphy C; Davidson TM; Quiñonez C; Jalowayski AA; Ellison DW
Laryngoscope; 1996 Jun; 106(6):739-44. PubMed ID: 8656960
[TBL] [Abstract][Full Text] [Related]
40. Patients' Perspectives on Qualitative Olfactory Dysfunction: Thematic Analysis of Social Media Posts.
Parker JK; Kelly CE; Smith BC; Kirkwood AF; Hopkins C; Gane S
JMIR Form Res; 2021 Dec; 5(12):e29086. PubMed ID: 34904953
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
